Get the Full Story, Without the Noise.
Published loading...Updated

FesariusTherapeutics Announces Manufacturing Agreement for DermiSphere hDRT, the first hydrogel Dermal Regeneration Template

Summary by Stemwell Science News
FesariusTherapeutics, Inc. announced it has entered into an exclusive, multi-year manufacturing and supply agreement with Regenity Biosciences. The agreement provides Regenity exclusive manufacturing responsibility for DermiSphere hDRT, an new class of collagen-based dermal regeneration templates. [FesariusTherapeutics, Inc. ] Press Release
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Stemwell Science News broke the news in on Thursday, May 1, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.